Chronic non specific low back pain. Biomechanical lesions, not elsewhere classified
Conditions
Interventions
Intervention 1: In this study there are two interventional groups:
One of them receive both drug therapy (NSAID) and soft lumbar corsets with usual compression on abdomen and the other receive both dr
Treatment - Other
Treatment - Drugs
In this study there are two interventional groups:
One of them receive both drug therapy (NSAID) and soft lumbar corsets with usual compression on abdomen and the other receive both drug therapy (NSA
Control group
use of NSAID for 4 weeks
Sponsors
Vice chancellor of research, Shiraz University of Medical Science
Eligibility
Sex/Gender
All
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: Major inclusion criteria Subjects aged between 25-55 years; low back pain for at least 3 months; the presence of pain in back and lower extremities; the minimum VAS Score of 4 out of 10; the minimum ODI score of 20 out of 50; lumbar flexion and extension ROM of 50% or higher; ability to walk independently without any assistive device; well enough to participate and able to complete the Oswestery Disability Index (ODI) questionnaire. Major exclusion criteria Acute trauma; fracture and instability or subluxation of the spine; fracture or luxation of pelvic and lower extremities; pregnancy; neoplastic and pathologic diseases such as fever and involuntary weight loss, infectious diseases, inflammatory diseases; neurologic diseases, and psychological disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trunk flexor and extensor strength. Timepoint: Before intervention and 4 weeks after. Method of measurement: Isokinetic biodex. | — |
Secondary
| Measure | Time frame |
|---|---|
| Trunk flexor and extensor electromyographic activity. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: EMG device.;Trunk proprioception in flexion and extension direction. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: Isokinetic biodex.;Pain. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: VAS score.;Trunk flexor and extensor endurance. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: Isokinetic biodex.;Function. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: Oswestry questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahbobeh Samani
Shiraz University of Medical Science
Outcome results
None listed